Literature DB >> 12604387

[Apolipoprotein E and bleomycin hydrolase. Polymorphisms: association with neurodegenerative diseases].

V Nivet-Antoine1, M-P Coulhon, C Le Denmat, B Hamon, X Dulcire, M Lefebvre, F Piette, P Davous, D Durand, D Duchassaing.   

Abstract

Several studies indicate a possible association between different genes and chronic neurodegenerative diseases including Alzheimer's disease (DTA). To further investigate, we have analyzed association between the apolipoprotein E (apo E) and bleomycin hydrolase (BH) polymorphisms and three groups of elderly patients: control subjects (T) (n = 68), late-onset sporadic DTA patients (DTAst) (n = 65) and other non vascular neurodegerative diseases (MNDA) (n = 52). Apo E-epsilon4 and BH-G alleles frequencies (%) are: 8.2 (T), 31.5 (DTAst), 16.4 (MNDA) and 41.4 (T), 35.6 (DTAst). No association has been observed between carrying the G allele and DTA in epsilon4 negative subjects but, our data have confirmed the earlier reports: carrying the epsilon4 allele is a dose-dependent risk factor for the DTAst (OR: 6.0, IC 95 %: 2.6-13.7) and decrease the age of symptom onset (p < 0.005). They have also suggested that apo E genotyping may be of interest to perform differential diagnosis of neurodegenerative diseases in elderly subjects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604387

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  2 in total

1.  Analysis of association between bleomycin hydrolase and apolipoprotein E polymorphism in Alzheimer's disease.

Authors:  Mohamed Ali Smach; Bassem Charfeddine; Turkia Lammouchi; Leila Ben Othman; Afef Letaief; Souhir Nafati; Hedi Dridi; Soufien Bennamou; Khalifa Limem
Journal:  Neurol Sci       Date:  2010-03-03       Impact factor: 3.307

2.  Genetic-linkage mapping of complex hereditary disorders to a whole-genome molecular-interaction network.

Authors:  Ivan Iossifov; Tian Zheng; Miron Baron; T Conrad Gilliam; Andrey Rzhetsky
Journal:  Genome Res       Date:  2008-04-16       Impact factor: 9.043

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.